Market Place
Sourcing Support
Dipharma Granted CADIFA By ANVISA For Ursodeoxycholic Acid
15 Oct 2024 //
PRESS RELEASE
US FDA grants accelerated approval to Genfit and Ipsen`s liver disease drug
11 Jun 2024 //
REUTERS
Axplora`s Ursodeoxycholic Receives 5-Year Renewed Registration
07 Nov 2023 //
PRESS RELEASE
Aurobindo`s Generic Ursodiol Receives Approval in the U.S.
28 Nov 2022 //
FDA
Bon Secours Liver Institute of Richmond Participating in RESPONSE Study
03 Feb 2022 //
GLOBENEWSWIRE
Liver Institute NW Participating in RESPONSE, a Global Phase 3 Research Study
01 Feb 2022 //
GLOBENEWSWIRE
Commerce ministry begins anti-dumping probe against ursodeoxycholic acid
28 Jan 2022 //
PHARMABIZ
The Texas Liver Institute Participating in RESPONSE, a Global Phase 3 Clinical
02 Nov 2021 //
GLOBENEWSWIRE
Pinnacle Clinical Research, PLLC Participating in RESPONSE, a Global Phase 3
02 Nov 2021 //
GLOBENEWSWIRE
HighTide’s HTD1801 Demonstrates improved effects in Diabetic NASH Patients
21 Sep 2021 //
BUSINESSWIRE
Vgyaan`s Generic Ursodiol Receives Approval In US
28 Jul 2021 //
FDA
Strides gets USFDA nod for Ursodiol tablets, a liver disease treatment drug
21 Aug 2020 //
ECONOMICTIMES
Strides Pharma`s Generic Ursodiol Receives Approval In US
20 Aug 2020 //
FDA
Upsher Smith`s Generic Ursodiol Approved in US
20 Aug 2020 //
FDA
Nexgen Pharma`s Generic Ursodiol Receives Approval in US
13 May 2020 //
FDA
CPQ ingenieros conducts the new lebsa plant remodeling
04 Mar 2020 //
CPQ
Rising Pharms Generic Ursodiol Receives Approval In US
15 Feb 2020 //
FDA
Eywa Pharma`s Generic Ursodiol Receives Approval in US
31 Oct 2019 //
FDA
Morepen Labs introduces three new API drugs
15 Oct 2019 //
PHARMABIZ
Genfit bags FDA breakthrough tag en route to phase 3 in PBC
18 Apr 2019 //
FIERCE BIOTECH
CymaBay Therapeutics` Seladelpar FDA Breakthrough Therapy Designated
15 Feb 2019 //
GLOBENEWSWIRE
Zydus `s Generic Ursodiol Receives Approval in US
31 Oct 2018 //
FDA
Amneal Pharms`s Generic Ursodiol Receives Approval in US
19 Oct 2018 //
FDA
Abhai’s Generic Ursodiol Receives Approval In US
22 May 2018 //
FDA
US FDA says excessive Ocaliva poses risk to people with decreased liver function
27 Sep 2017 //
IN PHARMATECHNOLOGIST
European Commission Grants Intercept’s Ocaliva Marketing Authorization
15 Dec 2016 //
GLOBENEWSWIRE
3 Potential Acquisition Targets for Gilead Sciences, Inc.
16 Nov 2016 //
THE MOTLEY FOOL
Eight Medicines win CHMP Nod
18 Oct 2016 //
PHARMATIMES
Intercept’s Ocaliva Gains PBC Thumbs in Europe, but with Caveats
15 Oct 2016 //
FIERCE BIOTECH
Apotheca Supply, Inc receives warning letter due to cGMP deviations
07 Apr 2016 //
FDA
FDA staff raises no major concerns over Intercept`s liver drug
06 Apr 2016 //
REUTERS
FDA postpones decision on Intercept`s lead liver drug
18 Dec 2015 //
REUTERS
Autoimmune liver disease - Are there spectra that we do not know?
11 Dec 2015 //
7TH SPACE
PBC Drug Lowers ALP
17 Nov 2015 //
MEDPAGE TODAY
Obeticholic Acid Durable in Primary Biliary Cirrhosis
16 Nov 2015 //
MEDPAGE TODAY
High-Dose Ursodeoxycholic Acid Fails Test in Primary Sclerosing Cholangitis
05 Nov 2015 //
MEDPAGE TODAY
Cerilliant Introduces Certified Spiking Solutions of Bile Acids
08 Oct 2015 //
PR NEWSWIRE
Canadian advance in solving brain disease
14 Sep 2015 //
RCI
Finding a way forward in the fight against prion disease
03 Sep 2015 //
EUREKALERT
Laparoscopic Cholecystectomy Prevent Recurrent Idiopathic Acute Pancreatitis?
31 Aug 2015 //
MEDSCAPE
FDA Grants Priority Review for Intercept`s Obeticholic Acid
31 Aug 2015 //
GLOBE NEWSWIRE
